A comparative study of originator G-CSF versus biosimilar G-CSF after autografting for hematological malignancies

被引：0
|
作者：
Bruno, B. [1 ]
Fornaro, M. J. [1 ]
Brunello, L. [1 ]
Giaccone, L. [1 ]
Scaldaferri, M. [2 ]
Redoglia, V. [1 ]
Omede, P. [1 ]
Festuccia, M. [1 ]
Ciccone, G. [3 ]
Massaia, M. [1 ]
Ferrero, D. [1 ]
Cavallo, F. [1 ]
Palumbo, A. [1 ]
Cattel, F. [2 ]
Evangelista, A. [3 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Turin, Dipartimento Biotecnol Mol & Sci Salute, AOU Citta Salute & Sci Torino, Turin, Italy
[2] AOU Citta Salute & Sci Torino, SC Farm, Turin, Italy
[3] AOU Citta Salute & Sci Torino, CPO Piemonte, Turin, Italy
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P042
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [31] Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO
    A Perillo
    G Ferrandina
    L Pierelli
    S Rutella
    S Mancuso
    G Scambia
    Bone Marrow Transplantation, 2004, 34 : 743 - 744
  • [32] Cytokines alone for PBPC collection in patients with advanced gynaecological malignancies: G-CSF vs G-CSF plus EPO
    Perillo, A
    Ferrandina, G
    Pierelli, L
    Rutella, S
    Mancuso, S
    Scambia, G
    BONE MARROW TRANSPLANTATION, 2004, 34 (08) : 743 - 744
  • [33] Prospective randomised study of PBSC mobilisation using intermediate dose cyclophosphamide and G-CSF versus G-CSF alone.
    Karanth, M
    Harvey, C
    Chakrabarti, S
    Holder, K
    McConkey, CC
    McDonald, D
    Lovell, RA
    Fegan, CD
    Milligan, DW
    BLOOD, 2002, 100 (11) : 826A - 826A
  • [34] ANALYSIS OF AUTOLOGOUS RECOVERY AND TRANSFUSIONAL REQUIREMENTS IN MOBILIZED TRANSPLANTATION WITH G-CSF plus PLERIXAFOR VERSUS G-CSF
    Raposo Puglia, J. A.
    Verdugo Cabeza de Vaca, M. V.
    Salamanca Cuenca, A.
    Correa Alonso, M. A.
    Ordonez Vahi, S.
    HAEMATOLOGICA, 2017, 102 : 112 - 113
  • [35] Comparable efficacy and safety of biosimilar and originator G-CSF in patients undergoing haematopoietic stem cell mobilisation
    Dmoszynska, A.
    Manko, J.
    Croneck, A.
    Grzasko, N.
    Klimek, P.
    Nowaczynska, A.
    Gorska-Kosicka, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S231 - S232
  • [36] Use of a biosimilar G-CSF in allogeneic stem cell mobilisation
    Azar, N.
    Choquet, S.
    Garnier, A.
    Weil, D. Roos
    Leblond, V.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S244 - S244
  • [37] Recent changes on the biopharmaceutical market after the introduction of biosimilar G-CSF products
    Zielinska, Joanna
    Bialik, Wlodzimierz
    ONCOLOGY IN CLINICAL PRACTICE, 2016, 12 (04): : 144 - 152
  • [38] Study of the rehabilitate effect of G-CSF on hematological function and its mechanism
    Fushe Yanjiu yu Fushe Gongyi Xuebao/Journal of Radiation Research and Radiation Processing, 2000, 18 (02): : 142 - 147
  • [39] Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF
    Liu, FL
    Poursine-Laurent, J
    Link, DC
    BLOOD, 2000, 95 (10) : 3025 - 3031
  • [40] Expression of recombinant G-CSF receptor domains and their inhibitory role on G-CSF function
    Bakherad, Hamid
    Setayesh, Neda
    Gargari, Seyed Latif Mousavi
    Ebrahimizadeh, Walead
    Mavandadnejad, Faranak
    Faghfuri, Elnaz
    Ebrahimi, Soheila
    Heiat, Mohammad
    Shahpari, Mona
    Sepehrizadeh, Zargham
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2020, 15 (04) : 381 - 389
12345